Solid Biosciences Inc. (SLDB) Shareholders’ equity 2016–2022
Solid Biosciences Inc. (SLDB) shareholders’ equity at each fiscal year-end, per SEC filings.
$211.7MFY2022 · since FY2016: -$37.9M → $211.7M
| Fiscal year | Value | YoY |
|---|---|---|
| FY2022 | $211.7M | +1.7% |
| FY2021 | $208.2M | +57.6% |
| FY2020 | $132.1M | +65.0% |
| FY2019 | $80.0M | -36.1% |
| FY2018 | $125.2M | +311.3% |
| FY2017 | -$59.3M | -56.4% |
| FY2016 | -$37.9M | — |
Source: SEC XBRL filings · For reference only · Not investment advice